AXALBION THERAPEUTICS LIMITED
activeThis page is the public half. The full check adds sanctions lists (OFSI, OFAC, UN), the FCA register, Gazette and court records, disqualifications, each director's other companies and an adverse-media sweep, read into a plain-English verdict. No account; emailed in minutes.
4 officers resigned over the company's life.
Opens a LinkedIn name search. We cannot confirm identities: check the profile mentions this company before relying on it, and if nothing comes up the person may simply not be on LinkedIn.
Holdings under 25% do not appear on this register; the cap table above (when filed) shows them.
Tero's full due-diligence report reads the pitch deck, the market, the competition, the founders' track records and the digital footprint, cross-checked against 12+ official sources, with an adversarial pass before anything is stated.
Compiled from the Companies House public registers at the time shown; verify against the live register before acting. Register name matches are not identity confirmations. Tero is software. We are not a fund, we do not hold client money, and we do not provide investment advice or personal recommendations. Information, not tax or investment advice. Capital at risk.